River BioMedics develops 3D human heart models based on stem cell technology that are able to mimic the pumping function of the human heart. We have validated our models with a set of drugs known to affect the heart, and aim to sell the use of these models to pharmaceutical companies for them to develop their new drugs in exchange for upfront and milestone payments. We envision to revolutionize drug discovery!
Speaker: Lisanne Blauw, Co-founder & Business developer
Together with Marcelo Ribeiro (CEO/CSO) and Robert Passier (scientific advisor), Lisanne is co-founder of River BioMedics. She is currently working as a business developer for the start-up company. Lisanne did her PhD research in Leiden at the department of Medicine division of Endocrinology of the Leiden University Medical Center (LUMC), where she studied genetic determinants of cardiovascular disease. Currently, she is holding a Postdoc position at this department. Her background is in Medicine (BSc, LUMC), and at the moment she is finishing the last year of her Master’s degree in Biomedical Engineering at Delft University of Technology.
The audience picked Healthy Mind, Iova and PharmaCytics as their top 3 pitchers and of these the jury chose PharmaCytics as the winner of the Axon Innovation for Health Award.